Role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine Factor XII. 1979

H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007704 Kininogens Endogenous peptides present in most body fluids. Certain enzymes convert them to active KININS which are involved in inflammation, blood clotting, complement reactions, etc. Kininogens belong to the cystatin superfamily. They are cysteine proteinase inhibitors. HIGH-MOLECULAR-WEIGHT KININOGEN; (HMWK); is split by plasma kallikrein to produce BRADYKININ. LOW-MOLECULAR-WEIGHT KININOGEN; (LMWK); is split by tissue kallikrein to produce KALLIDIN. Cystatins, Kininogen,Kininogen,Prekinins,Prokinins,T-Kininogen,Thiostatin,Kininogen Cystatins,T Kininogen
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D011487 Protein Conformation The characteristic 3-dimensional shape of a protein, including the secondary, supersecondary (motifs), tertiary (domains) and quaternary structure of the peptide chain. PROTEIN STRUCTURE, QUATERNARY describes the conformation assumed by multimeric proteins (aggregates of more than one polypeptide chain). Conformation, Protein,Conformations, Protein,Protein Conformations
D002417 Cattle Domesticated bovine animals of the genus Bos, usually kept on a farm or ranch and used for the production of meat or dairy products or for heavy labor. Beef Cow,Bos grunniens,Bos indicus,Bos indicus Cattle,Bos taurus,Cow,Cow, Domestic,Dairy Cow,Holstein Cow,Indicine Cattle,Taurine Cattle,Taurus Cattle,Yak,Zebu,Beef Cows,Bos indicus Cattles,Cattle, Bos indicus,Cattle, Indicine,Cattle, Taurine,Cattle, Taurus,Cattles, Bos indicus,Cattles, Indicine,Cattles, Taurine,Cattles, Taurus,Cow, Beef,Cow, Dairy,Cow, Holstein,Cows,Dairy Cows,Domestic Cow,Domestic Cows,Indicine Cattles,Taurine Cattles,Taurus Cattles,Yaks,Zebus
D004789 Enzyme Activation Conversion of an inactive form of an enzyme to one possessing metabolic activity. It includes 1, activation by ions (activators); 2, activation by cofactors (coenzymes); and 3, conversion of an enzyme precursor (proenzyme or zymogen) to an active enzyme. Activation, Enzyme,Activations, Enzyme,Enzyme Activations
D005174 Factor XII Stable blood coagulation factor activated by contact with the subendothelial surface of an injured vessel. Along with prekallikrein, it serves as the contact factor that initiates the intrinsic pathway of blood coagulation. Kallikrein activates factor XII to XIIa. Deficiency of factor XII, also called the Hageman trait, leads to increased incidence of thromboembolic disease. Mutations in the gene for factor XII that appear to increase factor XII amidolytic activity are associated with HEREDITARY ANGIOEDEMA TYPE III. Coagulation Factor XII,Hageman Factor,Factor 12,Factor Twelve
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
January 1987, Seminars in thrombosis and hemostasis,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
June 1985, Journal of biochemistry,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
January 1978, Agents and actions,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
October 1983, The Journal of laboratory and clinical medicine,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
January 1989, Advances in experimental medicine and biology,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
January 1983, Advances in experimental medicine and biology,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
November 1976, Thrombosis research,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
July 1983, Thrombosis research,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
August 2002, The Journal of biological chemistry,
H Kato, and T Sugo, and N Ikari, and N Hashimoto, and I Maruyama, and Y N Han, and S Iwanaga, and S Fujii
August 1981, Journal of biochemistry,
Copied contents to your clipboard!